Related Experiment Video
Updated: Mar 24, 2026

07:38
A General Method for Detecting Nitrosamide Formation in the In Vitro Metabolism of Nitrosamines by Cytochrome P450s
Published on: September 25, 2017
10.8K
In Vitro and In Vivo Characterization of the Alkaloid Nuciferine
Martilias S Farrell1, John D McCorvy1, Xi-Ping Huang1,2
1Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America.
Plos One
|March 11, 2016
Summary
Nuciferine, a compound from the sacred lotus, exhibits antipsychotic-like properties. This research validates its potential as an atypical antipsychotic by examining its effects in various pharmacological models.
Area of Science:
- Pharmacology
- Neuroscience
- Phytochemistry
Background:
- Sacred lotus (Nelumbo nucifera) contains numerous phytochemicals with a history of human use.
- Nuciferine, an alkaloid from Nelumbo nucifera and Nymphaea caerulea, was predicted to have a molecular profile similar to antipsychotic compounds.
- This study aimed to characterize nuciferine's pharmacological actions.
Purpose of the Study:
- To investigate the potential psychotropic effects of nuciferine, an alkaloid found in the sacred lotus.
- To characterize nuciferine's molecular and pharmacological profile using in silico, in vitro, and in vivo assays.
- To evaluate nuciferine's potential as an atypical antipsychotic agent.
Main Methods:
- In silico analysis using the similarity ensemble approach and the National Institute of Mental Health's Psychoactive Drug Screening Program.
- In vivo pharmacological assays in rodent models, including head-twitch response, pre-pulse inhibition, hyperlocomotor activity, and drug discrimination.
- Characterization of nuciferine's receptor binding profile and its effects on various behavioral paradigms relevant to antipsychotic drug action.
Main Results:
- Nuciferine demonstrated a receptor binding profile analogous to aripiprazole-like antipsychotics, acting as an antagonist, inverse agonist, partial agonist, agonist, and dopamine transporter inhibitor at various receptors (e.g., 5-HT2A, D2, 5-HT1A).
- In vivo, nuciferine modulated behaviors relevant to antipsychotic efficacy, including blocking head-twitch responses, substituting for clozapine in drug discrimination, and rescuing phencyclidine-induced deficits in prepulse inhibition.
- Nuciferine exhibited antipsychotic-like actions without inducing catalepsy and modulated locomotor activity in response to amphetamine and phencyclidine.
Conclusions:
- Nuciferine possesses an atypical antipsychotic-like molecular profile, sharing similarities with approved antipsychotic drugs.
- The pharmacological actions of nuciferine suggest its potential as a novel therapeutic agent for psychiatric disorders.
- Further research into nuciferine is warranted to explore its full therapeutic potential and mechanisms of action.

